IMF Bentham Ltd records 152% rise in profit: Is it too late to buy?

IMF Bentham Ltd (ASX:IMF) recorded a massive increase in income and profits in the first-half of 2015.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Litigation funder IMF Bentham Ltd (ASX: IMF) released its half-year profit results after the market's close on Monday, revealing a massive lift in income and profits compared to the same period in 2014.

So What: Over the period, a total of 10 cases were concluded (compared to just two in the corresponding period), which helped the company grow net profit by 152% to $23.01 million on the back of a 131% lift in total income from litigation contracts to $77.64 million. Meanwhile, it improved its cash position considerably to $134.4 million as at 31 December 2014 (from $105.58 million at 30 June 2014), and kept its interim dividend at 5 cents per share.

As impressive as the report may seem at first glance; investors need to remember just how erratic earnings can be in the litigation industry. In the 2014 financial year for instance, net profit fell 29% which resulted in a 41% fall in earnings per share (EPS). For this reason, the company does not provide forecasts for future periods, but did state that it had commenced nine new cases during the period which have a maximum claim value of $221 million as at 31 December 2014.

IMF Bentham isn't the only legal company posting strong results today with Slater & Gordon Limited (ASX: SGH) also lifting profit and revenues by 46.5% and 37.6% respectively.

Now What: Despite the lumpy earnings, IMF Bentham is a well-run company which continues to expand internationally, whilst also improving its reputation for success. While the stock is trading at a 52-week high of $2.26, it could still deliver excellent returns for investors over the coming years.

An even better bet than IMF Bentham

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »